The Cost-Effectiveness of Using Epoetin-Beta Versus Darbepoetin-Alfa for the Treatment of Anemia Among Chronic Hemodialysis Patients

Background and objective Anemia is a common prognosis of chronic kidney disease (CKD). It is predominantly managed with synthetic erythropoietin. The principal objective of this study was to compare the cost-effectiveness of the use of short-acting erythropoietin with the long-acting one to maintain...

Descripción completa

Detalles Bibliográficos
Autores principales: AlKharboush, Hanan, Alshehri, Fatimah, Alatwi, Ibrahim, Al Karni, Khaled, Alatawi, Abdurahman, Hamdan, Ahmed M
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cureus 2020
Materias:
Nephrology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7781860/
https://www.ncbi.nlm.nih.gov/pubmed/33415047
http://dx.doi.org/10.7759/cureus.11895

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7781860/
https://www.ncbi.nlm.nih.gov/pubmed/33415047
http://dx.doi.org/10.7759/cureus.11895

Ejemplares similares